Kartos Therapeutics names Dr. Srdan Verstovsek chief medical officer

Srdan Verstovsek, MD, PhD, has been appointed chief medical officer of Kartos Therapeutics, a clinical stage biopharmaceutical company developing therapeutics for patients with cancer.

Advertisement

Dr. Verstovsek joins Kartos with decades of experience as a physician-scientist, according to a March 2 release. He has been affiliated with the University of Texas MD Anderson Cancer Center in Houston since 1988 as a hematologist-oncologist and professor of medicine.

Dr. Verstovsek has also served as director of the Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms, the world’s largest MPN clinical research center.

Advertisement

Next Up in Chief Medical Officers

  • The Joint Commission has appointed Arjun Srinivasan, MD, as deputy chief medical officer.  According to a Nov. 10 news release…

  • Here are 10 chief medical officer appointments or exits reported by Becker’s between Oct. 1 and Oct. 31: 1. Jack…

Advertisement

Comments are closed.